Back

Choose your region

FamiCord is number 1 in Europe and number 5 in the World

According to recent publication by Parents Guide Cord Blood Foundation – FamiCord Group, founded by Polski Bank Komórek Macierzystych (PBKM), proudly stands as the leading cord blood banking network in Europe. Recognized globally, FamiCord has been acknowledged by international databases as a top player in the field, securing its position among the world’s top 10 cord blood banks. This recognition underscores the trust placed in FamiCord’s services by families across Europe and beyond.

Operating in most European markets, FamiCord’s extensive network ensures accessibility to life-saving stem cell banking services for countless families. With multiple laboratories strategically located across Europe, FamiCord provides unparalleled flexibility and efficiency in processing and storing cord blood and tissue. This robust infrastructure allows the group to meet the diverse needs of families while maintaining the highest standards of safety and quality.

Globally, FamiCord shares this prestigious ranking with other notable leaders in cord blood banking. In North America, companies like CBR (Cord Blood Registry) and ViaCord dominate the private banking market. In Asia, Cryo-Save India and Cordlife represent major players, reflecting the global reach and importance of stem cell banking. In the southern hemisphere, Cryosite in Australia ensures families in Oceania have access to these critical medical resources.

With over 4 million privately banked cord blood and tissue units worldwide, the industry is transforming the way families prepare for potential medical needs. FamiCord continues to play a critical role in this evolution, setting benchmarks for quality and reliability.

By collaborating with hospitals, healthcare providers, and researchers, FamiCord ensures that its services remain at the forefront of stem cell therapy advancements. The group also supports initiatives to raise awareness about the life-saving potential of cord blood banking, helping more families make informed decisions about their healthcare options.

As FamiCord expands its presence and services across Europe and beyond, it remains dedicated to its founding mission: empowering families with cutting-edge medical solutions and ensuring access to advanced regenerative medicine. This recognition as a European leader highlights not only the group’s achievements but also its ongoing commitment to shaping the future of healthcare worldwide.

Recently added

  • Infantile cerebral palsy – Convincing evidence for the use of perinatal stem cells Leipzig, July 15, 2025 - Cerebral palsy (CP) continues to be one of the most common motor disabilities in childhood and is associated with permanent movement restrictions and spasticity. The therapeutic potential of stem cells from umbilical cord blood and tissue was discussed at the 37th Annual Meeting of the European Academy Of Childhood-onset Disabilities (EACD) and the 4th Meeting of the International Alliance of Academies of C hildhood Disability (IAACD) from June 24 - 28, 2025 in Heidelberg. As part of a symposium supported by FamiCord AG, international experts presented the current state of research and reported on the results from clinical practice. Read more
  • FamiCord Group’s Dubai Laboratory Earns Prestigious AABB Accreditation Dubai, UAE – [3.06.2025] – FamiCord Group, the largest cord blood bank in Europe, proudly announces that its state-of-the-art laboratory in Dubai has received the prestigious accreditation from the Association for the Advancement of Blood & Biotherapies (AABB) – a globally recognized standard of excellence in the field of cellular and blood banking services. Read more